Tirofiban Hydrochloride Patent Expiration
Tirofiban Hydrochloride is Used for reducing thrombotic coronary events in patients with acute coronary syndrome. It was first introduced by Medicure International Inc
Tirofiban Hydrochloride Patents
Given below is the list of patents protecting Tirofiban Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Aggrastat | US5733919 | Compositions for inhibiting platelet aggregation |
Oct 23, 2016
(Expired) | Medicure |
| Aggrastat | US5733919 | Compositions for inhibiting platelet aggregation |
Oct 23, 2016
(Expired) | Medicure |
| Aggrastat | US5965581 | Compositions for inhibiting platelet aggregation |
Oct 23, 2016
(Expired) | Medicure |
| Aggrastat | US5972967 | Compositions for inhibiting platelet aggregation |
Oct 23, 2016
(Expired) | Medicure |
| Aggrastat | US5978698 | Angioplasty procedure using nonionic contrast media |
Oct 08, 2017
(Expired) | Medicure |
| Aggrastat | US6136794 | Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist |
Jan 29, 2019
(Expired) | Medicure |
| Aggrastat | US6770660 | Method for inhibiting platelet aggregation |
May 01, 2023
(Expired) | Medicure |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Tirofiban Hydrochloride Generics
Several generic applications have been filed for Tirofiban Hydrochloride. The first generic version for Tirofiban Hydrochloride was by Gland Pharma Ltd and was approved on Apr 8, 2021. And the latest generic version is by Nexus Pharmaceuticals Llc and was approved on Jul 24, 2023.
Given below is the list of companies who have filed for Tirofiban Hydrochloride generic.
1. NEXUS
Nexus Pharmaceuticals Llc has filed for 2 different strengths of generic version for Tirofiban Hydrochloride. Given below are the details of the strengths of this generic introduced by Nexus.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Feb 7, 2023 |
| EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Jul 24, 2023 |
2. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Tirofiban Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | May 1, 2023 |
| EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | May 1, 2023 |
3. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Tirofiban Hydrochloride. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Apr 8, 2021 |